Intestinal Haemorrhage and Colitis Induced by Treatment With Osimertinib for Non-Small-Cell Lung Carcinoma: A Case Report

• Váldodahkkit: Wang Shujun (Dahkki), Lou Lili (Dahkki), Yang Lei (Dahkki), Wang Feng (Dahkki), Zhan Hefeng (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Osimertinib is recommended either as the first-line therapy for sensitizing EGFR-mutations (FLAURA trial) or at progression to first-/second-generation EGFR inhibitors in the presence of resistance mutation T790M (AURA 3 study). It can effectively improve the prognosis of patients with N...